Main aspects of the clinical course of coronary heart disease in patients with coronavirus infection

Authors: Bockeria L.A., Donakanyan S.A., Dzhobava E.R., Patsoeva I.M., Radin V.V.

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation

UDC: 616.12-008.46:578.834.11
DOI: https://doi.org/10.24022/1810-0694-2023-24-1-19-23

Cite as: Bockeria L.A., Donakanyan S.A., Dzhobava E.R., Patsoeva I.M., Radin V.V. Main aspects of the clinical course of coronary heart disease in patients with coronavirus infection. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2023; 24 (1): 19–23 (in Russ.). DOI: 10.24022/1810-0694-2023-24-1-19-23

Received / Accepted: 09.11.2022 / 24.01.2023

Keywords: coronavirus infection coronary heart disease pandemic

Download

Abstract

Over the past few years, coronavirus infection (COVID-19) has been a global problem, the role of which in the disability and mortality of the population has become paramount. A number of researchers note the unprecedented impact of COVID-19 not only on public health, but also on the social and economic components of the normal life of people. The presence of coronary heart disease in patients with COVID-19 is one of the factors that aggravates the clinical course of the disease and contributes to the development of life-threatening complications. Myocardial damage due to a cytokine storm contributes to its structural restructuring, the consequences of which can be recorded in the long-term period after a COVID-19 infection. The increase in complaints and their persistence in the post-COVID period requires an appeal to a cardiologist and a comprehensive additional examination.

References

Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W. et al. Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 588 (7836): E6. Erratum in: Nature. 2020; 579 (7798): 270–3. DOI: 10.1038/s41586-020-2951-z
Nishiga M., Wang D.W., Han Y., Lewis D.B., Wu J.C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 2020; 17 (9): 543–58. Epub 2020 Jul 20. DOI: 10.1038/s41569-020-0413-9
Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181 (2): 271–80.e8. Epub 2020 Mar 5. DOI: 10.1016/j.cell.2020.02.052
Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 2020; 20 (6): 363–74. Epub 2020 Apr 28. DOI: 10.1038/s41577-020-0311-8
Shlyakho E.V., Konradi A.O., Arutyunov G.P., Arutyunov A.G., Bautin A.E., Boytsov S.A. et al. Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic. Russian Journal of Cardiology. 2020; 25 (3): 3801 (in Russ.). DOI: 10.15829/1560-4071-2020-3-3801
Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiol. 2020; 5 (7): 831–40. DOI: 10.1001/jamacardio.2020.1286
Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. COVID-19 and cardiovascular disease. Circulation. 2020; 141 (20): 1648–55. DOI: 10.1161/CIRCULATIONAHA.120.046941. Epub 2020 Mar 21.
Driggin E., Madhavan M.V., Bikdeli B., Chuich T., Laracy J., Biondi-Zoccai G. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J. Am. Coll. Cardiol. 2020; 75 (18): 2352–71. Epub 2020 Mar 19. DOI: 10.1016/j.jacc.2020.03.031 9. Yue H., Bai X., Wang J., Yu Q., Liu W., Pu J. et al. Clinical characteristics of coronavirus disease 2019 in Gansu province, China. Ann. Palliat. Med. 2020; 9 (4): 1404–12. DOI: 10.21037/apm-20-887
Xie J., Tong Z., Guan X., Du B., Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open. 2020; 3 (4): e205619. Erratum in: JAMA Netw Open. 2020; 3 (5): e208147. DOI: 10.1001/jamanetworkopen.2020.5619
Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for disease control and prevention. JAMA. 2020; 323 (13): 1239–42. DOI: 10.1001/jama.2020.2648
Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M. et al. ST-elevation myocardial infarction in patients with COVID-19: Clinical and angiographic outcomes. Circulation. 2020; 141 (25): 2113–6. Epub 2020 Apr 30. DOI: 10.1161/CIRCULATIONAHA.120.047525
Deng Q., Hu B., Zhang Y., Wang H., Zhou X., Hu W. et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int. J. Cardiol. 2020; 311: 116–21. Epub 2020 Apr 8. DOI: 10.1016/j. ijcard.2020.03.087
Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020; 382 (18): 1708– 20. Epub 2020 Feb 28. DOI: 10.1056/NEJMoa2002032
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30. DOI: 10.1016/S0140-6736(20)30183-5
Shi S., Qin M., Cai Y., Liu T., Shen B., Yang F. et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur. Heart J. 2020; 41 (22): 2070–9. DOI: 10.1093/eurheartj/ehaa408
Wang D., Li S., Jiang J., Yan J., Zhao C., Wang Y. et al. Chinese Society of Cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis. Sci. China Life Sci. 2019; 62 (2): 187–202. Epub 2018 Dec 3. DOI: 10.1007/s11427-018-9385-3
Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari R., Shah B. et al. ST-segment elevation in patients with Covid-19 – a case series. N. Engl. J. Med. 2020; 382 (25): 2478–80. Epub 2020 Apr 17. DOI: 10.1056/NEJMc2009020
Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M. et al. ST-elevation myocardial infarction in patients with COVID-19: Clinical and angiographic outcomes. Circulation. 2020; 141 (25): 2113–6. Epub 2020 Apr 30. DOI: 10.1161/CIRCULATIONAHA.120.047525
Libby P., Tabas I., Fredman G., Fisher E.A. Inflammation and its resolution as determinants of acute coronary syndromes. Circ. Res. 2014; 114 (12): 1867–79. DOI: 10.1161/CIRCRESAHA.114.302699
Bentzon J.F., Otsuka F., Virmani R., Falk E. Mechanisms of plaque formation and rupture. Circ. Res. 2014; 114 (12): 1852–66. DOI: 10.1161/CIRCRESAHA.114.302721
Chen T., Wu D., Chen H., Yan W., Yang D., Chen G. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368: m1091. Erratum in: BMJ. 2020; 368: m1295. DOI: 10.1136/bmj.m1091
Mehra M.R., Ruschitzka F. COVID-19 illness and heart failure: A missing link? JACC Heart Fail. 2020; 8 (6): 512–4. Epub 2020 Apr 10. DOI: 10.1016/j. jchf.2020.03.004
Nishiga M., Wang D.W., Han Y., Lewis D.B., Wu J.C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 2020; 17 (9): 543–58. Epub 2020 Jul 20. DOI: 10.1038/s41569-020-0413-9
Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5 (11): 1265–73. Erratum in: JAMA Cardiol. 2020; 5 (11): 1308. DOI: 10.1001/jamacardio.2020.3557
Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan C. et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc. Imaging. 2020; 13 (11): 2330–9. Epub 2020 May 12. DOI: 10.1016/j. jcmg.2020.05.004
Nuzzi V., Castrichini M., Collini V., Roman-Pognuz E., Di Bella S., Luzzati R. et al. Impaired right ventricular longitudinal strain without pulmonary hypertension in patients who have recovered from COVID-19. Circ. Cardiovasc. Imaging. 2021; 14 (4): e012166. Epub 2021 Apr 8. DOI: 10.1161/CIRCIMAGING.120.012166
Knight R., Walker V., Ip S., Cooper J.A., Bolton T., Keene S. et al. Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales. Circulation. 2022; 146 (12): 892–906. Epub 2022 Sep 19. DOI: 10.1161/CIRCULATIONAHA.122.060785

About the authors

Leo A. Bockeria, Academician of Russian Academy of Sciences, President of the Center; ORCID
Sergey A. Donakanyan, Dr. Med. Sci., Cardiovascular Surgeon; ORCID
Esma R. Dzhobava, Cand. Med. Sci., Cardiologist; ORCID
Iman M. Patsoeva, Postgraduate, Cardiologist; ORCID
Vladislav V. Radin, Postgraduate, Cardiovascular Surgeon; ORCID

News

Chief Editor

Elena Z. Golukhova, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery

Sort by

Если вы заметили опечатку, выделите текст и нажмите alt+A